Amifostine Prophylaxis

Amifostine Prophylaxis is a pharmacological intervention in renal protection that involves the administration of amifostine as a cytoprotective agent to selectively mitigate nephrotoxicity induced by cisplatin-based chemotherapy or radiation exposure.

17

Publications

648

Citations

81

Authors

26

Institutions

Publications per year

2017–2026

1

Authors

81

  1. VK
    Vijay K. Singh

    Uniformed Services University of the Health Sciences, United States

    3 publications · 111 citations

    3

    h-index

  2. TM
    Thomas M. Seed

    Uniformed Services University of the Health Sciences, United States

    3 publications · 111 citations

    3

    h-index

  3. MS
    M. Synodinou

    Metaxa Hospital, Greece

    2 publications · 252 citations

    2

    h-index

  4. DA
    D. Antonadou

    Metaxa Hospital, Greece

    2 publications · 252 citations

    2

    h-index

  5. NT
    N. Throuvalas

    Metaxa Hospital, Greece

    2 publications · 252 citations

    2

    h-index

1–5 of 81

Venues

  1. PubMed

    Repository · 4 publications · 86 citations

    4

    h-index

  2. 2

    h-index

  3. 1

    h-index

  4. Bone

    1 publications · 15 citations

    1

    h-index

  5. Cancer Chemotherapy and Pharmacology

    1 publications · 48 citations

    1

    h-index

1–5